Cardiovascular Pharmacotherapy and Glucose Metabolism: The Good, the Bad and the Unsightly.

Saved in:
Bibliographic Details
Title: Cardiovascular Pharmacotherapy and Glucose Metabolism: The Good, the Bad and the Unsightly.
Authors: Bianchettin RG; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA., Poirier P; Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, 2725 Chemin Ste-Foy, Québec, QC, G1V 4G5, Canada.; Faculté de Pharmacie, Université Laval, Québec, QC, Canada., Lopez-Jimenez F; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA., Lavie CJ; John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, LA, USA., Piché ME; Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, 2725 Chemin Ste-Foy, Québec, QC, G1V 4G5, Canada. marie-eve.piche.1@ulaval.ca.; Faculté de Médecine, Université Laval, Québec, QC, Canada. marie-eve.piche.1@ulaval.ca.
Source: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2026 May; Vol. 26 (3), pp. 269-281. Date of Electronic Publication: 2025 Nov 17.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-187X
DOI:10.1007/s40256-025-00777-2